Dr. Alexander Hanjoon Song, MD

Dr. Song practices at Good Samaritan Medical Pavilion in Los Angeles, California.

Dr. Song's NPI, 1265964795, was assigned on April 3, 2017. Dr. Song graduated from Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School in 2017. Dr. Song holds California license A184827.

Dr. Song's primary practice is Good Samaritan Medical Pavilion, at 1245 W Wilshire Blvd, Los Angeles, CA 90017 in Los Angeles County. The practice phone is (213) 977-1214.

Dr. Song's primary practice is Good Samaritan Medical Pavilion in Los Angeles, California. Dr. Song is also affiliated with PIH Health Good Samaritan Hospital. The medical group on file is Los Angeles Cancer Network. Dmand AI also links Dr. Song to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Song practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Song's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Song is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Song's licenses on file in 2 states: California and North Carolina.

Dmand AI lists chronic anemia and purpura and thrombocytopenia among the conditions Dr. Song treats.

CMS data shows 1,938 Medicare services from Dr. Song across 14 procedure codes in 2024, for 169 Medicare patients. Medicare paid $67,191 for them.

CMS counts 169 Medicare patients who saw Dr. Song in 2024. The largest group is 65 to 74, with 70 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 80% are also on Medicaid. Their average risk score is 2.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Song's median patient age at 62, with 63% women.

In 2024, Dr. Song wrote 912 Medicare Part D claims for 165 patients. 66% of them were for generic drugs. CMS names the drug for 687 of them, across 31 drugs with 11 or more claims each, at $1,524,810 in total drug cost. In 2023, CMS named 35 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Song for performance year 2024, reported as part of a group. Dr. Song accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Song as offering telehealth.

Dmand AI links 2 papers to Dr. Song in 2021. 2021 was the busiest year, with 2. Dr. Song's most frequent co-authors are Kimberly Marie Burcher, MD, Andrew Thomas Faucheux, MD and Thomas William Lycan, DO.

CMS Open Payments shows 537 general payments to Dr. Song from 67 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 98% of the total. Pfizer Inc. paid the most, $1,131.

Dr. Song graduated from Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School in 2017.

Dr. Song is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.